Adaptin Bio (APTN) Enterprise Value (2022 - 2026)
Adaptin Bio (APTN) posted Enterprise Value of -$301309.0 for Q1 2026, up 34.38% sequentially from -$459174.0 in Q4 2025, and up 87.31% YoY from -$160861.8 in Q1 2025.
Adaptin Bio (APTN) Enterprise Value (2022 - 2026) Analysis & Trends
Adaptin Bio has reported Enterprise Value for 5 years, with the latest figure at -$301309.0 in Q1 2026.
- Quarterly Enterprise Value rose 87.31% year-over-year to -$301309.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$301309.0 (up 87.31% YoY) and the FY2025 annual result came in at -$459174.0, down 1247.14% from the prior year.
- Enterprise Value rose to -$301309.0 in Q1 2026 per APTN's latest filing, from -$459174.0 in the prior quarter.
- Over five years, Enterprise Value peaked at -$322.0 in Q3 2024 and troughed at -$2.4 million in Q1 2025.
- A 5-year average of -$427849.7 and a median of -$28930.5 in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2025 and 2026: Enterprise Value sank 179741.3% in 2025, then soared 87.31% in 2026.
- Over 5 years, Enterprise Value stood at -$500.0 in 2022, then tumbled by 850.8% to -$4754.0 in 2023, then plunged by 616.98% to -$34085.0 in 2024, then sank by 1247.14% to -$459174.0 in 2025, then surged by 34.38% to -$301309.0 in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$301309.0, -$459174.0, and -$579089.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -670,488.00 |
| Mar 31, 2026 | -301,309.00 |
| Dec 31, 2025 | -459,174.00 |
| Sep 30, 2025 | -579,089.00 |
| Jun 30, 2025 | -1.35 Mn |
| Mar 31, 2025 | -2.37 Mn |
| Dec 31, 2024 | -34,085.00 |
| Sep 30, 2024 | -322.00 |
| Jun 30, 2024 | -23,776.00 |
| Mar 31, 2024 | -5,059.00 |
| Dec 31, 2023 | -4,754.00 |
| Sep 30, 2023 | -380.00 |
| Dec 31, 2022 | -500.00 |